Comparative anti-infammatory potential of crystalline and amorphous nano curcumin in topical drug delivery

Journal of Oleo Science

Volumn 64, Issue 1, 2015, Pages 27-40

  Al Rohaimi, Abdulmohsen H ^a  

^a SHAQRA UNIVERSITY   (Saudi Arabia)

Author keywords

Anti infammatory; Curcumin; Nanoemulsion; Permeation fux; Phase diagram; Thermodyanamic stability

Indexed keywords

BIOCHEMISTRY; DROPS; DRUG DELIVERY; PHASE DIAGRAMS; SIZE DISTRIBUTION; SURFACE ACTIVE AGENTS; TITRATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTI-INFAMMATORY; ANTI-INFLAMMATORY EFFECTS; CURCUMIN; DROPLET SIZE DISTRIBUTIONS; ENHANCEMENT RATIOS; NANOEMULSION; SHORT TERM STORAGE; TOPICAL DRUG DELIVERIES;

CRYSTALLINE MATERIALS;

ACRYLIC ACID DERIVATIVE; ANTIINFLAMMATORY AGENT; CARBOMER; CURCUMIN; EMULSION; GEL; NANOPARTICLE; SURFACTANT;

ANIMAL; CHEMISTRY; COMPARATIVE STUDY; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; EMULSION; GEL; MALE; PARTICLE SIZE; PHYSICAL CHEMISTRY; THERMODYNAMICS; TOPICAL DRUG ADMINISTRATION; TRANSMISSION ELECTRON MICROSCOPY; WISTAR RAT;

ACRYLATES; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CRYSTALLIZATION; CURCUMIN; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; GELS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; RATS, WISTAR; SURFACE-ACTIVE AGENTS; THERMODYNAMICS;

EID: 84920150359     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.ess14175     Document Type: Article

References (43)

1. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Ag-garwal, B. B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4, 807-818 (2007).
2. Pan, M. H.; Huang, T. M.; Lin, J. K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 27, 486-494 (1999).
3. Dhillon, N.; Aggarwal, B. B.; Newman, R. A.; Wolff, R. A.; Kunnumakkara, A. B.; Abbruzzese, J. L.; Ng, C. S.; Badmaev, V.; Kurzrock, R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14, 4491-4499 (2008).
4. Sharma, R. A.; Euden, S. A.; Platton, S. L.; Cooke, D. N. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin Cancer Res. 10, 6847-6854 (2004).
5. Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming, S. W. Phase I Clinical Trial of Curcumin, a Chemopreventive Agent, in Patients with High-Risk or Pre-Malignant Lesions. Anticancer Res. 21, 2895-2900 (2001).
6. Lin, J. K.; Pan, M. H.; Lin-Shiau, S. Y. Recent studies on the biofunctions and biotransformations of curcumin. Bio Factors 13, 153-158 (2000).
7. Dhawan, B.; Aggarwal, G.; Harikumar, S. Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int. J. Pharm. Investig. 4, 65-76 (2014).
8. Shakeel, F; Ramadan, W.; Ahmed, M. A. Investigation of true nanoemulsions for transdermal potential of in-domethacin: characterization, rheological characteristics, and ex vivo skin permeation studies. J. Drug Target. 7, 435-441 (2009).
9. Shakeel, F; Ramadan, W.; Faisal, M. S.; Rizwan, M.; Faiyazuddin, M.; Mustafa, G.; Shafiq, S. Transdermal and Topical Delivery of Anti-inflammatory Agents Using Nanoemulsion/ Microemulsion: An Updated Review. Curr Nano Sci 6, 184-198 (2010).
10. Ammar, H. O.; Ghorab, M.; El-Nahhas, S. Design of a transdermal delivery system for aspirin as an antithrombotic drug. Int. J. Pharm. 327, 81-88 (2006).
11. Guo, J.; Ping, Q.; Sun, G.; Jiao, C. Lecithin vesicular carriers for transdermal delivery of Cyclosporin A. Int. J. Pharm. 194, 201-207 (2000).
12. Chen, M.; Liu, X.; Fahr, A. Skin penetration and deposition of carboxy fluorescein and temoporfin from different lipid vesicular systems: in-vitro study with finite and infinite dosage application. Int. J. Pharm. 408, 223-234 (2011).
13. Talegaonkar, S.; Mustafa, G.; Akhter, S.; Iqbal, Z. I. Design and Development of Oral Oil-in Water Nanoemulsion Formulation Bearing Atorvastatin: In vitro Assessment. J. Disp. Sci. Tech. 30, 1-12 (2009).
14. Faiyazuddin, M.; Akhtar, N.; Akhter, J.; Suri, S.; Shakeel, F; Shafiq, S.; Mustafa, G. Production, characterization, in vitro and ex vivo studies of babchi oil-encapsulated nanostructured solid lipid carriers produced by a hot aqueous titration method. Pharmazie 65, 347-354 (2010).
15. Mustafa, G.; Khan, Z. I.; Bansal, T.; Talegaonkar, S. Preparation and Characterization of Oil in Water Nano-Reservoir Systems for Improved Oral Delivery of Atorvastatin. Curr. Nano Sci. 5, 428-440 (2009).
16. Faiyazuddin, M.; Akhtar, J.; Mustafa, G. Formulation of tea tree essential oil-loaded nanoemulsion system using aqueous titration method: In vitro and ex vivo kinetics. Int. J. Essen. Oil Thera. 3 13-21 (2009).
17. Mustafa, G.; Baboota, S.; Ahuja, A.; Ali, J. Formulation Development of Chitosan Coated Intra Nasal Ropini-role Nanoemulsion for Better Management Option of Parkinson: An In Vitro Ex Vivo Evaluation. Curr. Nano Sci. 8, 348-360 (2012).
18. Anwer, M. K; Jamil, S.; Ibnouf, E. O.; Shakeel, F Enhanced antibacterial effects of clove essential oil by nanoemulsion. J. Oleo Sci. 63, 347-354 (2014).
19. Wintr, C. A.; Risley, E. A.; Nuss, G. W.; Carrageenin-in-duced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111, 544-547 (1962).
20. Ghosh, M. N. Fundamentals of experimental Pharmacology, Third edition 2005; Page no, 192-193. Hilton and Company, Kolkata, INDIA.
21. Sharma, S.; Kulkarni, S. K; Agrewala, J. N.; Chopra, K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur. J. Pharmacol. 536, 256-261 (2006).
22. Banerjee, M.; Tripathi, L. M.; Srivastava, V. M.; Puri, A.; Shukla, R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immun. Pharmacol. Immunotoxi-col. 25, 213-224 (2003).
23. Joe, B.; Rao, U. J.; Lokesh, B. R. Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Mol. Cell Biochem. 169, 125-134 (1997).
24. Rao, J.; McClements, D. J. Formation of flavor oil mi-croemulsions, nanoemulsions and emulsions: influence of composition and preparation method. J. Agric. Food Chem. 59, 5026-5035 (2011).
25. Wakisaka, S.; Nakanishi, M.; Gohtani, S. Phase behavior and formation of o/w nano-emulsion in vegetable oil/ mixture of polyglycerol polyricinoleate and polyg-lycerin fatty acid ester/water systems. J. Oleo Sci. 63, 229-237 (2014).
26. Lawrence, M. J.; Rees, G. D. Microemulsion based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45, 89-121 (2000).
27. Craig, D. Q. M.; Barker, S. A.; Banning, D. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm. 114, 103-110 (1995).
28. Ruckenstein, E.; Chi, J. C. Stability of microemulsion. J. Chem. Soc. Faraday Trans. 71, 1690-1707 (1975).
29. Wennerstrom, H.; Olsson, U. Microemulsion as model systems. C. R. Chimie 12, 4-17 (2009).
30. Huibers, P. D. T.; Shah, D. O. Evidence for Synergism in Nonionic Surfactant Mixtures: Enhancement of Solubilization in Water-in-Oil Microemulsions. Langmuir 13, 5762-5765 (1997).
31. Deleurence, R.; Parneix, C; Monteux, C. Mixtures of latex particles and the surfactant of opposite charge used as interface stabilizers influence of particle contact angle, zeta potential, flocculation and shear energy. Soft Matter. PMID: 25008289 (2014).
32. Thakkar, P. J.; Madan, P.; Lin, S. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation. Pharm. Dev. Technol. 19, 373-384 (2014).
33. Schleich, N.; Preat, V. Nanostructures overcoming the skin barriers: Drug delivery strategy: In ch 6.2 by Maria, J. A.; Noemi, S.C. Nanostructure biomaterials for overcoming biolologicas barriers: The Royal Society of Chemistry, UK (2012).
34. Zatz, J. L.; Lee. B. Skin penetration enhancement by surfactants, Marcel Dekker, New York, (1997).
35. Scheuplein, R. J.; Blank, I. H. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 60, 286-296 (1973).
36. McKenzie, A. W.; Stoughton, R. B. Percutaneous Absorption of Steroids. Arch. Dermatol. 86, 611-614 (1962).
37. Behl, C. R.; Flynn, G. L.; Kurihara, T.; Harper, N.; Smith, W.; Higuchi, W. I.; Ho, N. F.; Pierson, C. L. Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin. J. Invest. Dermatol. 75, 346-352 (1980).
38. Derjaguin, B. V.; Landau, L. D. Theory of the stability of strongly charged lyophobic sols and the adhesion of strongly charged particles in solutions of electrolyte. Acta Physicochimica URSS 14, 633-662 (1941).
39. Raison, C. L.; Capuron, L.; Miller, A. H. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 27, 24-31 (2006).
40. Bengmark, S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic diseases. J. Parenter Enter. Nut. 30, 45-51 (2006).
41. Jackson, J.; Higo, T; Hunter, W.; Burt, H. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm. Res. 55, 168-175 (2006).
42. Patil, U. K.; Saraogi, R. Natural products as potential drug permeation enhancer in transdermal drug delivery system. Arch. Dermatol. Res. 306, 419-26 (2014).
43. Gao, Z. S.; Wang, L.; Zhang, M. Effects of penetration enhancers on curcumin transdermal drug delivery. Zhong Yao Cai 35, 141-4 (2012).